Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 1, 2015, Pages 11-31

  Yahalom, Joachim ^a   Illidge, Tim ^b   Specht, Lena ^c   Hoppe, Richard T ^d   Li, Ye Xiong ^e   Tsang, Richard ^f   Wirth, Andrew ^g  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STANFORD UNIVERSITY   (United States)

^e CANCER HOSPITAL   (China)

^f UNIVERSITY OF TORONTO   (Canada)

^g PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIATION; RADIOTHERAPY;

INTERNATIONAL COMMISSION; NON-HODGKIN LYMPHOMA; RADIATION ONCOLOGY; SALVAGE TREATMENT; SYSTEMIC THERAPY; TECHNICAL CHALLENGES; TREATMENT MODALITY; TREATMENT PLANNING;

ONCOLOGY;

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

BREAST LYMPHOMA; BREATH HOLDING; CANCER RADIOTHERAPY; CANCER SIZE; CATARACTOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; CORNEA ULCER; DRUG MEGADOSE; DUODENUM LYMPHOMA; DURA MATER LYMPHOMA; EXTRANODAL LYMPHOMA; FLUOROSCOPY; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; HYPOPHARYNX; INTRAOCULAR LYMPHOMA; LARGE CELL LYMPHOMA; LARYNX; LUNG LYMPHOMA; LYMPHOCYTOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MOUTH CAVITY; NEOVASCULAR GLAUCOMA; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; NOSE CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OPTIC NERVE ATROPHY; OVERALL SURVIVAL; PARANASAL SINUS; PERIPHERAL T CELL LYMPHOMA; PHARYNX; PRACTICE GUIDELINE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION FIELD; RETINOPATHY; REVIEW; STOMACH LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME; VISUAL IMPAIRMENT; ABDOMINAL NEOPLASMS; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; EYE NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; NOSE NEOPLASMS; ORBITAL NEOPLASMS; PATHOLOGY; THYROID NEOPLASMS; TUMOR VOLUME; UROGENITAL NEOPLASMS;

ABDOMINAL NEOPLASMS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; EYE NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; NOSE NEOPLASMS; ORBITAL NEOPLASMS; ORGAN SPECIFICITY; RADIOTHERAPY DOSAGE; THYROID NEOPLASMS; TUMOR BURDEN; UROGENITAL NEOPLASMS;

EID: 84927539056     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.009     Document Type: Review

References (77)

1. R. Newton, J. Ferlay, and V. Beral The epidemiology of non-hodgkin's lymphoma: Comparison of nodal and extra-nodal sites Int J Cancer 72 1997 923 930
2. T. Illidge, L. Specht, and J. Yahalom Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group Int J Radiat Oncol Biol Phys 89 2014 49 58
3. J. Yahalom Radiotherapy of follicular lymphoma: Updated role and new rules Curr Treat Options Oncol 15 2014 262 268
4. L. Lowry, P. Smith, and W. Qian Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial Radiother Oncol 100 2011 86 92
5. P.J. Hoskin, A.A. Kirkwood, and B. Popova 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial Lancet Oncol 15 2014 457 463
6. A.D. Zelenetz, L.I. Gordon, and W.G. Wierda Non-Hodgkin's lymphomas, version 4.2014 J Natl Compr Canc Netw 12 2014 1282 1303
7. B.S. Hoppe, C.H. Moskowitz, and D.A. Filippa Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity J Clin Oncol 26 2008 1858 1864
8. J. Yahalom Management of relapsed and refractory Hodgkin's disease Semin Radiat Oncol 6 1996 210 224
9. L. Specht, J. Yahalom, and T. Illidge Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG) Int J Radiat Oncol Biol Phys 89 2014 854 862
10. V. Gregoire, and T.R. Mackie State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report no. 83) Cancer Radiother 15 2011 555 559
11. S.A. Milgrom, and J. Yahalom The role of radiation therapy in the management of primary central nervous system lymphoma Leuk Lymphoma 2014 1 8 [Epub ahead of print]
12. A.M. Omuro, L.S. Ben-Porat, and K.S. Panageas Delayed neurotoxicity in primary central nervous system lymphoma Arch Neurol 62 2005 1595 1600
13. A.J. Ferreri, C. Verona, and L.S. Politi Consolidation radiotherapy in primary central nervous system lymphomas: Impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy Int J Radiat Oncol Biol Phys 80 2011 169 175
14. G.D. Shah, J. Yahalom, and D.D. Correa Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma J Clin Oncol 25 2007 4730 4735
15. D.D. Correa, M. Rocco-Donovan, and L.M. DeAngelis Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy J Neurooncol 91 2009 315 321
16. P.G. Morris, D.D. Correa, and J. Yahalom Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: Final results and long-term outcome J Clin Oncol 31 2013 3971 3979
17. A.F. Hottinger, L.M. DeAngelis, and J. Yahalom Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma Neurology 69 2007 1178 1182
18. P.L. Nguyen, A. Chakravarti, and D.M. Finkelstein Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma J Clin Oncol 23 2005 1507 1513
19. R. Lai, M.K. Rosenblum, and L.M. DeAngelis Primary CNS lymphoma: A whole-brain disease? Neurology 59 2002 1557 1562
20. A.J. Ferreri How I treat primary CNS lymphoma Blood 118 2011 510 522
21. Y. Shibamoto, N. Hayabuchi, and J. Hiratsuka Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation Cancer 97 2003 128 133
22. E.K. Akpek, I. Ahmed, and F.H. Hochberg Intraocular-central nervous system lymphoma: Clinical features, diagnosis, and outcomes Ophthalmology 106 1999 1805 1810
23. S.A. Grimm, C.A. McCannel, and A.M. Omuro Primary CNS lymphoma with intraocular involvement: International PCNSL collaborative group report Neurology 71 2008 1355 1360
24. S. Teckie, and J. Yahalom Primary intraocular lymphoma: Treatment outcomes with ocular radiation therapy alone Leuk Lymphoma 55 2014 795 801
25. J.R. Smith, J.T. Rosenbaum, and D.J. Wilson Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement Ophthalmology 109 2002 1709 1716
26. D.R. Puri, W. Tereffe, and J. Yahalom Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: Treatment approach and review of published data Int J Radiat Oncol Biol Phys 71 2008 1425 1435
27. A. Stefanovic, and I.S. Lossos Extranodal marginal zone lymphoma of the ocular adnexa Blood 114 2009 501 510
28. C.Y. Fung, N.J. Tarbell, and M.J. Lucarelli Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes Int J Radiat Oncol Biol Phys 57 2003 1382 1391
29. J.S. Goda, M. Gospodarowicz, and M. Pintilie Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy Cancer 116 2010 3815 3824
30. M.R. Pfeffer, T. Rabin, and L. Tsvang Orbital lymphoma: Is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys 60 2004 527 530
31. V.S. Jeganathan, A. Wirth, and M.P. MacManus Ocular risks from orbital and periorbital radiation therapy: A critical review Int J Radiat Oncol Biol Phys 79 2011 650 659
32. K.H. Tran, B.A. Campbell, and T. Fua Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma Leuk Lymphoma 54 2013 491 496
33. M. Kaushik, J.S. Pulido, and S.E. Schild Risk of radiation retinopathy in patients with orbital and ocular lymphoma Int J Radiat Oncol Biol Phys 84 2012 1145 1150
34. C.O. Suh, S.J. Shim, and S.W. Lee Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior Int J Radiat Oncol Biol Phys 65 2006 228 233
35. H.F. Frierson Jr., S.E. Mills, and D.J. Innes Jr. Non-Hodgkin's lymphomas of the sinonasal region: Histologic subtypes and their clinicopathologic features Am J Clin Pathol 81 1984 721 727
36. M.D. Logsdon, C.S. Ha, and V.S. Kavadi Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy Cancer 80 1997 477 488
37. N. Murawski, G. Held, and M. Ziepert The role of radiotherapy and intrathecal cns prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas Blood 124 2014 720 728
38. L.M. Tran, R. Mark, and Y.S. Fu Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity: A report of 18 cases with stage Ie disease Am J Clin Oncol 15 1992 222 225
39. A.A. Ezzat, E.M. Ibrahim, and A.N. El Weshi Localized non-Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients Head Neck 23 2001 547 558
40. M. Gurkaynak, M. Cengiz, and S. Akyurek Waldeyer's ring lymphomas: Treatment results and prognostic factors Am J Clin Oncol 26 2003 437 440
41. S.N. Qi, Y.X. Li, and H. Wang Diffuse large B-cell lymphoma: Clinical characterization and prognosis of Waldeyer ring versus lymph node presentation Cancer 115 2009 4980 4989
42. D.T. Chang, N.P. Mendenhall, and J.W. Lynch Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring Am J Clin Oncol 32 2009 233 237
43. S. Laskar, P. Mohindra, and S. Gupta Non-Hodgkin lymphoma of the Waldeyer's ring: Clinicopathologic and therapeutic issues Leuk Lymphoma 49 2008 2263 2271
44. M. Mohammadianpanah, S. Omidvai, and A. Mosalei Treatment results of tonsillar lymphoma: A 10-year experience Ann Hematol 84 2005 223 226
45. Y. Anacak, R.C. Miller, and N. Constantinou Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: A multicenter rare cancer network study Int J Radiat Oncol Biol Phys 82 2012 315 320
46. A. Ambrosetti, R. Zanotti, and C. Pattaro Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection Br J Haematol 126 2004 43 49
47. R.W. Tsang, M.K. Gospodarowicz, and M. Pintilie Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome J Clin Oncol 21 2003 4157 4164
48. M. Alzouebi, J.R. Goepel, and J.M. Horsman Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre Int J Oncol 40 2012 2075 2080
49. L.J. Costa, and A.C. Xavier Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort Leuk Lymphoma 55 2014 283 287
50. S. Walsh, A.J. Lowery, and D. Evoy Thyroid lymphoma: Recent advances in diagnosis and optimal management strategies Oncologist 18 2013 994 1003
51. W.Y. Au, D.D. Weisenburger, and T. Intragumtornchai Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the international peripheral T-cell lymphoma project Blood 113 2009 3931 3937
52. Y.X. Li, Q.F. Liu, and H. Fang Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma Clin Cancer Res 15 2009 2905 2912
53. S.J. Kim, K. Kim, and B.S. Kim Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage Ie to IIe, nasal, extranodal NK/T-cell lymphoma: Consortium for improving survival of lymphoma study J Clin Oncol 27 2009 6027 6032
54. Z.Y. Wang, Y.X. Li, and W.H. Wang Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents Blood 114 2009 4771 4776
55. Y.X. Li, B. Yao, and J. Jin Radiotherapy as primary treatment for stage ie and iie nasal natural killer/t-cell lymphoma J Clin Oncol 24 2006 181 189
56. L.E. Abrey, J. Yahalom, and L.M. DeAngelis Treatment for primary CNS lymphoma: The next step J Clin Oncol 18 2000 3144 3150
57. H. Wang, Y.X. Li, and W.H. Wang Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma Int J Radiat Oncol Biol Phys 82 2012 1115 1121
58. Y.X. Li, H. Wang, and J. Jin Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma Int J Radiat Oncol Biol Phys 82 2012 1809 1815
59. M. Yamaguchi, Y.L. Kwong, and W.S. Kim Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-cell tumor study group study J Clin Oncol 29 2011 4410 4416
60. L. Wang, Z.J. Xia, and Y. Lu Prophylactic cervical lymph node irradiation provides no benefit for patients of stage Ie extranodal natural killer/T cell lymphoma, nasal type Med Oncol 32 2015 320
61. N. Tomita, T. Kodaira, and H. Tachibana A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma Br J Radiol 82 2009 756 763
62. X.W. Bi, Y.X. Li, and H. Fang High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome Int J Radiat Oncol Biol Phys 87 2013 1086 1093
63. Y.X. Li, H. Fang, and Q.F. Liu Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring Blood 112 2008 3057 3064
64. J. Caon, E.S. Wai, and J. Hart Treatment and outcomes of primary breast lymphoma Clin Breast Cancer 12 2012 412 419
65. G. Martinelli, G. Ryan, and J.F. Seymour Primary follicular and marginal-zone lymphoma of the breast: Clinical features, prognostic factors and outcome: A study by the international extranodal lymphoma study group Ann Oncol 20 2009 1993 1999
66. G. Ryan, G. Martinelli, and M. Kuper-Hommel Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the international extranodal lymphoma study group Ann Oncol 19 2008 233 241
67. S. Ahmed, A.K. Siddiqui, and K.R. Rai Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma Cancer Invest 20 2002 1059 1068
68. J. Yahalom MALT lymphomas: A radiation oncology viewpoint Ann Hematol 80 Suppl 3 2001 B100 B105
69. A. Wirth, M. Gospodarowicz, and B.M. Aleman Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: A retrospective, multi-centre, international extranodal lymphoma study group study Ann Oncol 24 2013 1344 1351
70. C. Della Biancia, M. Hunt, and E. Furhang Radiation treatment planning techniques for lymphoma of the stomach Int J Radiat Oncol Biol Phys 62 2005 745 751
71. A.P. Kiess, and J. Yahalom Primary follicular lymphoma of the gastrointestinal tract: Effect of stage, symptoms and treatment choice on outcome Leuk Lymphoma 54 2013 177 180
72. S.S. Ahmad, S.F. Idris, and G.A. Follows Primary testicular lymphoma Clin Oncol 24 2012 358 365
73. C.Y. Cheah, A. Wirth, and J.F. Seymour Primary testicular lymphoma Blood 123 2014 486 493
74. K. Beal, L. Allen, and J. Yahalom Primary bone lymphoma: Treatment results and prognostic factors with long-term follow-up of 82 patients Cancer 106 2006 2652 2656
75. A.P. Ng, A. Wirth, and J.F. Seymour Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure LeukLymphoma 48 2007 596 600
76. D.R. Ford, D. Wilson, and S. Sothi Primary bone lymphoma: Treatment and outcome Clin Oncol 19 2007 50 55
77. N.G. Mikhaeel Primary bone lymphoma Clin Oncol 24 2012 366 370